Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
Clinical trial NCT04655157 · TERMINATED
Trial details
- NCT number
- NCT04655157
- Sponsor
- Jason J. Luke, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2022-08-03
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.